Liquid Long-Acting Methylphenidate Preparation Now FDA Approved for ADHD

Beginning in January, physicians will have the new option of a liquid long-acting methylphenidate treatment that requires only once-daily dosing.  The medication, made by NextWave Pharmaceuticals (which will be sold to Pfizer), is called Quillivant XR and will be available at a 25mg/5ml (5mg/ml) concentration. The recommended starting dose for children 6 years old and […]

Tags: , ,

Finger Length Ratios Related to Child Aggression and Attention Problems

A proxy for the level of exposure to prenatal androgens is the length of the second finger digit relative to the length of the forth finger (although not all studies support this link). Lower ratios are generally associated with more male typical behaviors. A new study published in the journal Development and Psychopathology examines a […]

Tags: , , , ,

Trends in Antipsychotic Medication Use 1993-2009

A new study in the Archives of General Psychiatry reports on the increasing use of antipsychotic medications in youth.  The study analyzed nearly half a million medical visits over a 17 year span (1993 through 2009).  Results showed that the number of medical visits that included an antipsychotic medication per 100 persons rose in children […]

Tags: , ,

Drug Holidays During ADHD Treatment

With school ending and summer vacation starting, many parents of children with ADHD wonder whether or not it makes sense to do a “drug holiday” until school resumes in the Fall.  The Child Mind Institute recently provided some commentary on this issue for both parents and clinicians.  The bottom line answer, as it is for […]

Tags: ,

Rising Rates of Autism and ADHD: What are We to Make of This?

Several recent studies have reported continued increases in the rates of both ADHD and autistic spectrum disorders. For Autism, a new study from the CDC found an overall rate of 1 in 88 children (1 in 54 boys and 1 in 252 girls).  This rate is much higher than the 1 in 155 reported in […]

Tags: , , ,

Who Should Evaluate and Treat ADHD? The AAP’s Nudge

In October, the journal Pediatrics, based right here in Vermont, published updated guidelines from the American Academy of Pediatrics (AAP) regarding the assessment and treatment of ADHD.   Since its publication, what has clearly generated the most media discussion about these new guidelines is the inclusion of preschool children (age 4 and above) in the recommendations.  […]

Tags: , , ,

New NEJM Study Shows No Increased Cardiovascular Risk with ADHD Medications

by John Koutras, MD The use of ADHD drugs was not associated with an increased risk of serious cardiovascular events in children and young adults.  This was the overall finding of a new study published in the New England Journal of Medicine.  ADHD medications are prescribed for more than 2.7 million children in the US […]

Tags: ,